Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

Over the last 3 months, EPS estimates have seen 2 upward revisions and 12 downward. Revenue estimates have seen 3 upward revisions and 7 downward. Since the start of the year, 3M shares have risen 8.6 ...

Bank OZK (the "Bank") (Nasdaq: OZK) today announced that net income available to common stockholders for the fourth quarter of 2024 was $178.1 million ...

YARDLEY, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced ...

Rare Disease Segment performed in line with expectations, with Purified Cortrophin Gel net revenues of $197.8 million to $198 ...

Artificial intelligence (AI) developments are expected to continue to drive market trends, while small-cap and mid-cap stocks are forecasted to perform better in the coming year. U.S. stock ...

Tesla reports total 2024 deliveries of 1.79 million, down from full-year deliveries of 1.81 million ... storage deployments for all of 2024 were 31.4 GWh. Tesla also set the date for its upcoming ...

Tesla Inc TSLA has been a top performing large-cap stock in 2024 with shares up 70% ... the second day of the following month and with the market open Thursday after the New Year's Day holiday ...

Exit polls triggered a sharp knee-jerk rally of approximately 4% in a single ... of a possible full-scale regional crisis and significantly impacted Indian stock market investors' sentiment.

Tesla stock continued its slide Tuesday ... of more than 1.8 million vehicles was initially a bit shy of its full-year delivery expectations of 512,250 in Q4, a record. Despite hitting a strong ...